The best linear combinations of blood markers were selected by stepwise multi-discriminant analysis for the development of a novel model (NAFLD mark) based on five markers (CRP, cholesterol, BMI ALT, and miRNA-34). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.